Bunazosin hydrochloride reduces glutamate-induced neurotoxicity in rat primary retinal cultures

被引:5
作者
Goto, W
Ichikawa, M
Tanaka, E
Hara, H
Araie, M
机构
[1] Santen Pharmaceut Co Ltd, Ophthalm Res & Dev Div, Nara 6300101, Japan
[2] Univ Tokyo, Sch Med, Dept Ophthalmol, Tokyo 113, Japan
关键词
alpha(1)-adrenoceptor antagonist; bunazosin hydrochloride; glutamate; neuroprotection; primary retinal culture; Na+ channel;
D O I
10.1016/j.brainres.2003.12.030
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
To study neuroprotective effects of bunazosin hydrochloride which is an alpha(1)-adrenoceptor antagonist used as an ocular hypotensive drug compared to other alpha(1)-adrenoceptor antagonists, and its mechanism of action. We evaluated the neuroprotective effects of bunazosin hydrochloride or seven other alpha(1)-adrenoceptor antagonists against glutamate-induced cell death in rat primary retinal cultures. We also evaluated the binding inhibition of bunazosin hydrochloride for 24 different receptors/channels and its effects on the Na+ influx into cells induced by veratridine or glutamate. Bunazosin hydrochloride significantly inhibited glutamate-induced cell death at concentrations of 1 and 10 muM. Cells were also protected when treated with some alpha(1)-adrenoceptor antagonists, but not by the others. Bunazosin hydrochloride showed a high inhibition for Na+ channels and inhibited the Na+ influx induced by veratridine or glutamate. These findings indicate that in retinal cultures bunazosin hydrochloride has a neuroprotective effect against glutamate-induced cell death and that the inhibition of Na+ channels by bunazosin hydrochloride may be partly responsible for this effect. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:130 / 137
页数:8
相关论文
共 51 条
[1]  
AZUMA I, 1994, JPN REV CLIN OPHTHAL, V88, P1280
[2]  
AZUMA I, 1994, J EYE, V11, P631
[3]   Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist [J].
Baron, BM ;
Harrison, BL ;
Kehne, JH ;
Schmidt, CJ ;
VanGiersbergen, PLM ;
White, HS ;
Siegel, BW ;
Senyah, Y ;
McCloskey, TC ;
Fadayel, GM ;
Taylor, VL ;
Murawsky, MK ;
Nyce, P ;
Salituro, FG .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 323 (2-3) :181-192
[4]   Betaxolol, a β1-adrenoceptor antagonist, reduces Na+ influx into cortical synaptosomes by direct interaction with Na+ channels:: comparison with other β-adrenoceptor antagonists [J].
Chidlow, G ;
Melena, J ;
Osborne, NN .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (04) :759-766
[5]  
CREVELING CR, 1983, MOL PHARMACOL, V23, P350
[6]   Primate retina: Cell types, circuits and color opponency [J].
Dacey, DM .
PROGRESS IN RETINAL AND EYE RESEARCH, 1999, 18 (06) :737-763
[7]  
Donello JE, 2001, J PHARMACOL EXP THER, V296, P216
[8]  
GEISEN K, 1985, ARZNEIMITTEL-FORSCH, V35-1, P707
[9]   SPECTRUM OF THE MU-BINDING, DELTA-BINDING AND KAPPA-BINDING SITES IN HOMOGENATES OF RAT-BRAIN [J].
GILLAN, MGC ;
KOSTERLITZ, HW .
BRITISH JOURNAL OF PHARMACOLOGY, 1982, 77 (03) :461-468
[10]   Protective effects of timolol against the neuronal damage induced by glutamate and ischemia in the rat retina [J].
Goto, W ;
Ota, T ;
Morikawa, N ;
Otori, Y ;
Hara, H ;
Kawazu, K ;
Miyawaki, N ;
Tano, Y .
BRAIN RESEARCH, 2002, 958 (01) :10-19